Home Cart 0 Sign in  
X

[ CAS No. 102074-19-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 102074-19-1
Chemical Structure| 102074-19-1
Chemical Structure| 102074-19-1
Structure of 102074-19-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 102074-19-1 ]

Related Doc. of [ 102074-19-1 ]

Alternatived Products of [ 102074-19-1 ]

Product Details of [ 102074-19-1 ]

CAS No. :102074-19-1 MDL No. :MFCD08236816
Formula : C7H9NO Boiling Point : -
Linear Structure Formula :- InChI Key :MRQAYFYTWNIVFN-UHFFFAOYSA-N
M.W : 123.15 Pubchem ID :11962777
Synonyms :

Calculated chemistry of [ 102074-19-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.33
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.82 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 0.33
Log Po/w (WLOGP) : 0.73
Log Po/w (MLOGP) : 0.22
Log Po/w (SILICOS-IT) : 1.65
Consensus Log Po/w : 0.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.24
Solubility : 7.11 mg/ml ; 0.0577 mol/l
Class : Very soluble
Log S (Ali) : -0.59
Solubility : 31.7 mg/ml ; 0.258 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.2
Solubility : 0.784 mg/ml ; 0.00637 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.1

Safety of [ 102074-19-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 102074-19-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 102074-19-1 ]
  • Downstream synthetic route of [ 102074-19-1 ]

[ 102074-19-1 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 29681-45-6 ]
  • [ 102074-19-1 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0℃; for 0.666667 h;
Stage #2: With water In tetrahydrofuran
General Procedure for the Synthesis of Intermediate Benzylbromo bromides; [0116] Typical romides[0117] Step 1. Methyl 5-methylnicotinate (10 mmol, 1.52g) was dissolved in 50 Ml dried THF, then cooled to 0 deg with ice-bath. LiAlH4 (16 mmol, 0.61g) was added in small portions during about 20 minutes. The mixture stirred for another 20 minutes until the reaction was completed, which monitored by TLC. 1.5 mL water was dropwised into the mixture to quench the reaction, then filtered, solution was concentrated to get the (5-methylpyridin-3-yl)methanol, Yield was high to 85percent
84% With sodium tetrahydroborate; sodium methylate In methanol Example-2
Synthesis of 5-methylpyridine-3-methanol (Formula-9) from 5-Methyl-nicotinic acid methyl ester (Formula-8)
5-methyl nicotinic acid methyl ester (Formula-8) (100.0 gm, 0.66 moles) in methanol (400 ml) and stir the reaction mass. Then add Sodium borohydride (36.72gm, 0.96 moles) and Sodium methoxide (10.68 gm, 0.2 moles) are added under continuously stirring. On completion of reaction, methanol is distilled the methanol and then MDC and water to the reaction mixture. pH of reaction mixture is adjusted to <2.5 by using HCl aqueous layer is separated and pH is adjusted to 9-10 using NaOH and then product is extracts using MDC. Saturated brine solution is added with stirring followed by separating MDC layer. MDC is distilled completely to obtained title intermediate compound. (64-68.0 g; Yield=79-84percent).
84.9% With potassium borohydride; magnesium chloride In tetrahydrofuran at 40 - 67℃; for 2.3 h; S2, Preparation of 5-methyl-3-pyridinemethanol:According to the molar portion of 2 parts of magnesium chloride,2 parts of potassium borohydride,Tetrahydrofuran mixture,The temperature was raised to 67 ° C,Reflux 2h,Cooled to room temperature to obtain a solution B;Methyl 5-methyl nicotinate obtained in S1 was added to tetrahydrofuran for dissolution,Adjust the temperature to 40 ,Solution B was added dropwise,Solution B was added dropwise within 1.3h,Insulation 1h,Dropping and insulation kept stirring process,Cooled to room temperature to obtain a solution C;The reaction was quenched by adding methanol,Warmed to 40 ° C,Rotary evaporation to remove tetrahydrofuran and methanol to give a concentrate D;After adding water to concentrate D,Add ethyl acetate extract,Co-extraction three times,The combined ethyl acetate phase,Add anhydrous sodium sulfate until the moisture content of 0.3wtpercentFiltering, taking ethyl acetate phase rotary evaporation 5-methyl-3-pyridine methanol;
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6299 - 6310
[2] Synthetic Communications, 2008, vol. 38, # 1, p. 122 - 127
[3] Patent: WO2012/97196, 2012, A1, . Location in patent: Page/Page column 34
[4] Patent: EP2824103, 2015, A1, . Location in patent: Paragraph 0040
[5] Patent: CN106560471, 2017, A, . Location in patent: Paragraph 0055; 0061; 0067; 0073; 0079; 0085; 0091; 0096
[6] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3513 - 3521
[7] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 6, p. 2206 - 2210
[8] Heterocyclic Communications, 2015, vol. 21, # 4, p. 203 - 205
[9] Patent: WO2016/185423, 2016, A1, . Location in patent: Page/Page column 74
  • 2
  • [ 92444-99-0 ]
  • [ 102074-19-1 ]
YieldReaction ConditionsOperation in experiment
76% With hydrogen; sodium acetate; palladium dichloride In methanol at 35℃; for 2 h; Typical procedures: 6-bromonicotinaldehyde (930 mg, 5.0 mmol), NaOAc (820 mg, 10.0 mmol), MeOH (30 mL), and PdCl2 (45 mg) were mixed in a glass bottle capped with a balloon filled with hydrogen. After stirred at 35 °C for 4 h, the mixture was filtered and washed with MeOH. The solvent was removed and the residue was dissolved in water, neutralized with solid NaHCO3, and extracted with ethyl acetate. The organic phase was dried over anhyd Na2SO4, and then filtered. The solvent was removed and the residue was subjected to chromatography to yield pyridin-3-ylmethanol (428 mg, 78percent).
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 29, p. 3798 - 3801
  • 3
  • [ 3222-49-9 ]
  • [ 102074-19-1 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3513 - 3521
[2] Patent: WO2006/110668, 2006, A1, . Location in patent: Page/Page column 56
[3] Patent: WO2006/110668, 2006, A1, . Location in patent: Page/Page column 61
[4] Patent: EP1230232, 2004, B1, . Location in patent: Page 39; 40
[5] Patent: WO2009/42694, 2009, A1, . Location in patent: Page/Page column 89
[6] Patent: EP2824103, 2015, A1,
[7] Heterocyclic Communications, 2015, vol. 21, # 4, p. 203 - 205
  • 4
  • [ 591-22-0 ]
  • [ 102074-19-1 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3513 - 3521
  • 5
  • [ 102074-19-1 ]
  • [ 100910-66-5 ]
YieldReaction ConditionsOperation in experiment
85% at 20℃; Step 2. 5-methyl-3-pyridinecarboxaldehyde. A mixture of 5-methyl-3-pyridinemethanol (106 mg, 0.86 mmol) and activated MnO2 (376 mg) in methylenechloride (10 mL) was stirred at room temperature overnight. The black solid of MnO2 was removed by filtration. The filtrate was concentrated in vacuo to yield the title compound as an oil (100 mg, 85percent). 1H NMR (CDCl3): 10.10 (s, 1H), 8.89 (s, 1H), 8.68 (s, 1H), 7.98 (s, 1H), 2.45 (s, 3H)
Reference: [1] Patent: EP1230232, 2004, B1, . Location in patent: Page 40
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6299 - 6310
[3] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3513 - 3521
[4] Patent: WO2016/185423, 2016, A1, . Location in patent: Page/Page column 74
  • 6
  • [ 102074-19-1 ]
  • [ 1235342-53-6 ]
YieldReaction ConditionsOperation in experiment
80% With hydrogen bromide In water for 5 h; Reflux Step 2.; Alcohol (10 mmol) were refluxed in 10ml HBr (40percent aq) for more than 5 hours, and monitored through TLC or LC-MS. After completed, mixture were heated in order to evaporator solvents (water and excess HBr) until the mixture became sticky. Cool the mixture, add acetone to the mixture, precipitated solid and filtered followed by drying. Yield was high to80percent.
Reference: [1] Patent: WO2012/97196, 2012, A1, . Location in patent: Page/Page column 34
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 102074-19-1 ]

Alcohols

Chemical Structure| 38070-80-3

[ 38070-80-3 ]

Pyridine-3,4-diyldimethanol

Similarity: 0.90

Chemical Structure| 120277-39-6

[ 120277-39-6 ]

(E)-3-(Pyridin-3-yl)prop-2-en-1-ol

Similarity: 0.90

Chemical Structure| 100-55-0

[ 100-55-0 ]

3-Pyridinemethanol

Similarity: 0.89

Chemical Structure| 187392-96-7

[ 187392-96-7 ]

(5-Phenylpyridin-3-yl)methanol

Similarity: 0.88

Chemical Structure| 201286-63-7

[ 201286-63-7 ]

(3,5-Dimethylpyridin-4-yl)methanol

Similarity: 0.88

Related Parent Nucleus of
[ 102074-19-1 ]

Pyridines

Chemical Structure| 38070-80-3

[ 38070-80-3 ]

Pyridine-3,4-diyldimethanol

Similarity: 0.90

Chemical Structure| 120277-39-6

[ 120277-39-6 ]

(E)-3-(Pyridin-3-yl)prop-2-en-1-ol

Similarity: 0.90

Chemical Structure| 100-55-0

[ 100-55-0 ]

3-Pyridinemethanol

Similarity: 0.89

Chemical Structure| 187392-96-7

[ 187392-96-7 ]

(5-Phenylpyridin-3-yl)methanol

Similarity: 0.88

Chemical Structure| 201286-63-7

[ 201286-63-7 ]

(3,5-Dimethylpyridin-4-yl)methanol

Similarity: 0.88